Evidence map›Paper›PMID 39333763›Full record

ArticleScientific reports2024

Heme deficiency in skeletal muscle exacerbates sarcopenia and impairs autophagy by reducing AMPK signaling.

Takeru Akabane, Hiromori Sagae, Koen van Wijk, Shinichi Saitoh, Tomohiro Kimura, Satoshi Okano, Ken Kodama, Kiwamu Takahashi, Motowo Nakajima, Tohru Tanaka and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. The Role ofInternational journal of general medicine · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Takeru AkabaneDepartment of Functional Genomics, Major of Innovative Medical Science Research, Yamagata University School of Medicine/Research Center for Molecular Genetics, Institute for Promotion of Medical Science Research, Yamagata University Faculty of Medicine, Iida-Nishi 2-2-2 Yamagata, Yamagata, 990-9585, Japan.
Hiromori SagaeDepartment of Functional Genomics, Major of Innovative Medical Science Research, Yamagata University School of Medicine/Research Center for Molecular Genetics, Institute for Promotion of Medical Science Research, Yamagata University Faculty of Medicine, Iida-Nishi 2-2-2 Yamagata, Yamagata, 990-9585, Japan.
Koen van WijkDepartment of Functional Genomics, Major of Innovative Medical Science Research, Yamagata University School of Medicine/Research Center for Molecular Genetics, Institute for Promotion of Medical Science Research, Yamagata University Faculty of Medicine, Iida-Nishi 2-2-2 Yamagata, Yamagata, 990-9585, Japan.
Shinichi SaitohDepartment of Functional Genomics, Major of Innovative Medical Science Research, Yamagata University School of Medicine/Research Center for Molecular Genetics, Institute for Promotion of Medical Science Research, Yamagata University Faculty of Medicine, Iida-Nishi 2-2-2 Yamagata, Yamagata, 990-9585, Japan.
Tomohiro KimuraDepartment of Functional Genomics, Major of Innovative Medical Science Research, Yamagata University School of Medicine/Research Center for Molecular Genetics, Institute for Promotion of Medical Science Research, Yamagata University Faculty of Medicine, Iida-Nishi 2-2-2 Yamagata, Yamagata, 990-9585, Japan.
Satoshi OkanoDepartment of Functional Genomics, Major of Innovative Medical Science Research, Yamagata University School of Medicine/Research Center for Molecular Genetics, Institute for Promotion of Medical Science Research, Yamagata University Faculty of Medicine, Iida-Nishi 2-2-2 Yamagata, Yamagata, 990-9585, Japan.
Ken KodamaKIYAN PHARMA Co., Ltd., Tokyo, Japan.
Kiwamu TakahashiSBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Motowo NakajimaSBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
Tohru TanakaKIYAN PHARMA Co., Ltd., Tokyo, Japan.
Michiaki TakagiDepartment of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan.
Osamu NakajimaDepartment of Functional Genomics, Major of Innovative Medical Science Research, Yamagata University School of Medicine/Research Center for Molecular Genetics, Institute for Promotion of Medical Science Research, Yamagata University Faculty of Medicine, Iida-Nishi 2-2-2 Yamagata, Yamagata, 990-9585, Japan. nakajima@med.id.yamagata-u.ac.jp.

Funding

JSPS KAKENHI (Grant-in-Aid for Scientific Research(C)) 18K06949
6 · The paper itself

Abstract

Heme serves as a prosthetic group in hemoproteins, including subunits of the mammalian mitochondrial electron transfer chain. The first enzyme in vertebrate heme biosynthesis, 5-aminolevulinic acid synthase 1 (ALAS1), is ubiquitously expressed and essential for producing 5-aminolevulinic acid (ALA). We previously showed that Alas1 heterozygous mice at 20-35 weeks (aged-A1

Indexed as

AMP-Activated Protein KinasesAutophagyHemeMuscle, SkeletalSarcopeniaSignal Transduction5-Aminolevulinate SynthetaseAminoimidazole CarboxamideAminolevulinic AcidAnimalsCell LineGlucoseMaleMiceRibonucleotides5-Aminolevulinate SynthetaseAICA ribonucleotideAminoimidazole CarboxamideAminolevulinic AcidAMP-Activated Protein KinasesGlucoseHemeRibonucleotides5-aminolevulinic acid5-aminolevulinic acid synthase 1 (ALAS1)AutophagyHemeSarcopeniaSkeletal muscle

Identifiers

PMID39333763
PMCPMC11437137

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.